Search - tctmd.com

Displaying 161 - 180 of 316

Sort: Relevancy | Date

Presentation THT 2026

Automated 99mTechnetium-Pyrophosphate Planar Scintigraphy Interpretation From Clinical Imaging PDFs Using a Vision-Enabled Reasoning Large Language Models

Presenter: Akshay Arora

March 03, 2026

Presentation THT 2026

Overview of Ongoing Studies with Gene Therapy for Cardiovascular Diseases

Presenter: Joe Rossano

March 03, 2026

Presentation THT 2026

Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis

Presenter: Hanna Gaggin

March 03, 2026

Presentation THT 2026

Bioelectric Regulation of Cardiac Remodeling in Heart Failure: Microcurrent Therapy

Presenter: Stefan Anker

March 03, 2026

Presentation THT 2026

The Special Cases of In- and Out-of Hospital Cardiac Arrest

Presenter: Maya Guglin

March 03, 2026

Presentation THT 2026

Identifying and Preventing Toxicity

Presenter: Eric D. Adler

March 03, 2026

Presentation THT 2026

Enhancing Risk Prediction With Novel Approaches To Define Cardiogenic Shock Phenotypes

Presenter: Jonas Sundermeyer

March 03, 2026

Presentation THT 2026

Wearable Cardiac Defibrillator for Newly Diagnosed HFrEF: Real World Evidence

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

SCAI Stages of Cardiogenic Shock: Past, Present and Future

Presenter: David A. Baran

March 03, 2026

Presentation THT 2026

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Cardiac Contractility Modulation: Combining CCM and ICD Therapy

Presenter: Nir Uriel

March 03, 2026

Presentation THT 2026

Designing Studies for Gene Therapy for Rare Diseases

Presenter: Barry Greenberg

March 03, 2026

Presentation THT 2026

Keeping Patients out of DanGer

Presenter: Jacob Eifer Moeller

March 03, 2026

Presentation THT 2026

Central Venous Congestion in Transcatheter Tricuspid Repair: Lessons from the TRI.Fr Trial

Presenter: Karl-Philipp Rommel

March 03, 2026

Presentation THT 2026

Barostimulation Therapy for HFrEF

Presenter: Philip Adamson, MD

March 03, 2026

Presentation THT 2026

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Defining the Targets for Gene Therapy and Optimizing Vectors for Delivery

Presenter: Roger J. Hajjar

March 03, 2026

Presentation THT 2026

Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

The Lymphatic System as a Target for ADHF

Presenter: Jan Biegus

March 03, 2026

Advertisement

Automated 99mTechnetium-Pyrophosphate Planar Scintigraphy Interpretation From Clinical Imaging PDFs Using a Vision-Enabled Reasoning Large Language Models

Overview of Ongoing Studies with Gene Therapy for Cardiovascular Diseases

Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis

Bioelectric Regulation of Cardiac Remodeling in Heart Failure: Microcurrent Therapy

The Special Cases of In- and Out-of Hospital Cardiac Arrest

Identifying and Preventing Toxicity

Enhancing Risk Prediction With Novel Approaches To Define Cardiogenic Shock Phenotypes

Wearable Cardiac Defibrillator for Newly Diagnosed HFrEF: Real World Evidence

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

SCAI Stages of Cardiogenic Shock: Past, Present and Future

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Cardiac Contractility Modulation: Combining CCM and ICD Therapy

Designing Studies for Gene Therapy for Rare Diseases

Keeping Patients out of DanGer

Central Venous Congestion in Transcatheter Tricuspid Repair: Lessons from the TRI.Fr Trial

Barostimulation Therapy for HFrEF

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Defining the Targets for Gene Therapy and Optimizing Vectors for Delivery

Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial

The Lymphatic System as a Target for ADHF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content